Mark Erlander, Chief Executive Officer at Cardiff Oncology, Inc. (CRDF), bought 10,000 shares at $1.43 ($14K) on 2022-11-25, disclosed to the SEC on 2022-11-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| TROV | BUY | 2016-12-15 | $10K | — | Filing → |